The Bextra debate

The American Heart Association's annual meeting convened in New Orleans in November, 2004. During this conference a leading heart researcher disclosed information about Bextra safety in terms of cardiovascular risks. This expert cited a recent study that indicated patients who take Bextra after cardiac bypass surgery are at an increased risk of suffering from cardiovascular complications, as compared to patients who had not taken Bextra after undergoing a similar surgical procedure.